2023
2022
Spermosens receives patent approval from the Japan Patent Office
2022
2022
Spermosens signs an agreement for the production of JUNO-checked instrument
2022
Spermosens signs letter of intent for production of JUNO-checked cassette
2022
2022
ISO 13485 certification
2022
Strengthening of the team
2022
2022
Patent granted in Hong Kong for Biosensor For Male Infertility valid until 2039
2021
JUNO-Checked® Instrument Prototype Finalized
2021
2021
EUROPEAN PATENT EP3768825 IS GRANTED WITH NATIONAL VALIDATION IN 16 COUNTRIES
2021
Spermosens appoints Advisory Board with leading KOLs
2021
2021
EMISSION PERIOD STARTED FOR LISTING ON SPOTLIGHT STOCKMARKET WITH ESTIMATED FIRST DAY OFF TRADING MAY 5th
2021
Clinical validation studies started at Oslo Metropolitan University
2021
2021
Application for national patent on all Spermosens target markets globally
2020
Application for national patent in EU according to PACE programme for rapid entry
2020
2020
Bull study at University in Murcia confirming JUNO as essential biomarker for male fertility
2020
PRELIMINARY REPORT ON PATENTABILITY (IPRP)
2020
2020
Spermosens becomes member of SmiLe Incubator
2020
Spermosens gets laboratory facility at Medicon Village
2020
2020
Spermosens receives support from Innovation Skåne
2020
Spermosens moves into The Spark, Medicon Village
2020
2019
SPERMOSENS BIOSENSOR DEVELOPED
2019
Proprietary JUNO and ZP3 proteins produced
2019
2019
Spermosens receives support from Vinnova
2018
Foundation of Spermosens
2018
2018
First patent application filed
2018
JUNO reported on human oocytes
2018
2014
Discovery of JUNO in mammals
2014
Early prototype with ZP3 established
2014
2012
Kush Punyani and Prof Sudha Srivastava conceptualise a fertility testing device
